Fraunhofer EMFT develops microfluidic actuators such as micropumps or microvalves for short- and long-term implantable applications. These include medication dosage for pain therapy, hormone dosage for the delivery of insulin/glucagon or the application of cytostatics in the fight against cancer. Furthermore, the implantable micropumps can deliver body fluids directly, as in glaucoma therapy, or be used as pneumatic or hydraulic actuators.